• Net sales below estimates, diligent cost control improves profitability • Activities to increase growth continues • Adjustments lead to a lower fair value of SEK 6.32 (7.25) per share
ANNONS
Despite lower sales, Precise Biometrics (Precise) reported a positive EBITDA for the quarter of MSEK 4.4. Revenue came in at MSEK 20.0 and costs decreased to MSEK 15.8. The company is still affected by the weak US dollar and a continued cautious market situation. The sales development has been flat since the start of the year, raising concerns among investors.
